Abolhasan Afkar1, Habib Jalilian2,3, Abolghasem Pourreza4, Habibeh Mir5, Abdolhosein Emami Sigaroudi6, Somayeh Heydari7. 1. Social Determinants of Health Research Center, School of Health, Guilan University of Medical Sciences, Rasht, Iran. 2. Assistant Professor, Department of Health Services Management, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. 3. Social Determinants of Health Research Center, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran. 4. Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 5. Student Research Committee, School of Management and Medical Informatics, Iran University of Medical Sciences, Tehran, Iran. 6. Cardiovascular Diseases Research Center, Department of Cardiology, School of Medicine, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, Iran. 7. School of Public Health, Guilan University of Medical Science, PO Box: 3391, Rasht, Iran. Saeedehheydari5@yahoo.com.
Abstract
BACKGROUNDS: Breast cancer is the most prevalent cancer among women. Breast cancer imposes a considerable economic burden on the health system. This study aimed to compare the cost of breast cancer among patients who referred to private and public hospitals in Iran (2017). METHODS: This was a prevalence-based cost of illness study. A total of 179 patients were selected from private and public hospitals using the census method. The researcher-constructed checklist was used for data collection. Data were analyzed using SPSS software version 22. RESULTS: The estimated total mean (SD) direct cost of patients who referred to the private hospital and the public hospital was $10,050 (19,480) and $3960 (6780), respectively. Further, the total mean indirect cost of patients who referred to the private hospital was lower than those referring to the public hospital at $1870 (15 % of total costs) and $22,350 (85 % of total costs), respectively. These differences were statistically significant (P < 0.05). CONCLUSIONS: Breast cancer imposes a substantial cost on patients, health insurance organizations and the whole society in Iran. Therefore, the adoption of effective measures for the prevention and early diagnosis of breast cancer is urgently needed.
BACKGROUNDS: Breast cancer is the most prevalent cancer among women. Breast cancer imposes a considerable economic burden on the health system. This study aimed to compare the cost of breast cancer among patients who referred to private and public hospitals in Iran (2017). METHODS: This was a prevalence-based cost of illness study. A total of 179 patients were selected from private and public hospitals using the census method. The researcher-constructed checklist was used for data collection. Data were analyzed using SPSS software version 22. RESULTS: The estimated total mean (SD) direct cost of patients who referred to the private hospital and the public hospital was $10,050 (19,480) and $3960 (6780), respectively. Further, the total mean indirect cost of patients who referred to the private hospital was lower than those referring to the public hospital at $1870 (15 % of total costs) and $22,350 (85 % of total costs), respectively. These differences were statistically significant (P < 0.05). CONCLUSIONS:Breast cancer imposes a substantial cost on patients, health insurance organizations and the whole society in Iran. Therefore, the adoption of effective measures for the prevention and early diagnosis of breast cancer is urgently needed.
Entities:
Keywords:
Breast cancer; Burden of disease; Cost of illness; Direct costs; Indirect costs
Authors: Mohammad H Forouzanfar; Kyle J Foreman; Allyne M Delossantos; Rafael Lozano; Alan D Lopez; Christopher J L Murray; Mohsen Naghavi Journal: Lancet Date: 2011-09-14 Impact factor: 79.321
Authors: Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2015-02-04 Impact factor: 508.702
Authors: Lindsey A Torre; Rebecca L Siegel; Elizabeth M Ward; Ahmedin Jemal Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-12-14 Impact factor: 4.254
Authors: Young Ae Kim; In-Hwan Oh; Seok-Jun Yoon; Hyun-Jin Kim; Hye-Young Seo; Eun-Jung Kim; Yo Han Lee; Jae Hun Jung Journal: Cancer Res Treat Date: 2015-02-13 Impact factor: 4.679
Authors: Francisco Winter Dos Santos Figueiredo; Tábata Cristina do Carmo Almeida; Débora Terra Cardial; Érika da Silva Maciel; Fernando Luiz Affonso Fonseca; Fernando Adami Journal: BMC Womens Health Date: 2017-11-28 Impact factor: 2.809